特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
921267

心臓構造デバイス市場 - 成長、傾向、予測

Structural Heart Devices Market - Growth, Trends, and Forecasts (2020 - 2025)

出版日: | 発行: Mordor Intelligence LLP | ページ情報: 英文 114 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.84円
心臓構造デバイス市場 - 成長、傾向、予測
出版日: 2020年06月01日
発行: Mordor Intelligence LLP
ページ情報: 英文 114 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

主要な構造的心臓病には、関連する適応症とともに、心房中隔欠損症、大動脈弁狭窄症、末梢動静脈瘻などがあります。開腹手術の代替手段として、低侵襲デバイスの採用が着実に増加しており、心臓構造デバイス市場の需要が拡大しています。また、 ヘルスケア費の改善、ベンチャーパートナーからの資金提供による革新的な医療機器企業への後押し、革新的なプロジェクトへの小規模ビジネスの革新調査の着実な参加により、心臓血管機器の需要が高まっています。

当レポートでは、心臓構造デバイスの世界市場を調査し、市場の概要、タイプ、処置、地域別の市場動向、市場規模の推移と予測、市場促進・阻害要因ならびに市場機会の分析、競合情勢、主要企業のプロファイルなど包括的な情報を提供しています。

目次

第1章 イントロダクション

  • 調査成果
  • 調査の前提条件
  • 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場のダイナミクス

  • 市場概要
  • 成長要因
  • 抑制要因
  • ファイブフォース分析
    • 新規参入の脅威
    • 消費者の交渉力
    • サプライヤーの交渉力
    • 代替製品の脅威
    • 業界内での競争

第5章 市場セグメンテーション

  • 製品別
    • 心臓弁装置
    • オクルーダー・デリバリーシステム
    • 弁輪形成リング
    • その他
  • 処置別
    • 交換
    • 修複
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • 中東・アフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Abbott Laboratories
    • Biomerics, LLC
    • Boston Scientific Corporation
    • Braile Biomedica
    • Comed BV
    • Edwards Lifesciences Corporation
    • JenaValve Technology, Inc.
    • Lepu Medical
    • LivaNova PLC
    • Medtronic PLC

第7章 市場機会および将来動向

目次
Product Code: 67126

In the modern advances of medical sciences, many medical heart device companies and institutes are focusing upon several ways to replace or repair structural heart diseases such as congenital and age-related heart defects.

There is a significant growth over the decade in the type of complexities which are presented by the cardiovascular patients. To curb them, structural heart devices play a significant role in the treatment of chronic heart disorders. The initiatives and awareness programs by the government and private sector in collaboration with cardiac specialized hospitals also drive the adoption of such devices in the healthcare facilities.

Some of the major structural heart diseases having a significant burden across the world include atrial septal defects, aortic stenosis, peripheral arteriovenous fistula, along with related indications. As an alternative to open surgeries, there has been a steady increase in the adoption of minimally invasive devices which also drives the demand for structural heart devices market, over the forecast period.

Key Market Trends

Replacement Procedures is Expected to Contribute to Significant Revenue Over the Forecast Period

The transcatheter aortic valve replacement (TAVR) is one of the noticeable advances under the replacement procedures segment, TAVR has gained attention because of growing adoption of minimally invasive surgical procedures. Under sedative medications, the procedure lasts for a shorter period than open heart surgery and is highly useful for patients with severe aortic stenosis (AS). In many multispeciality healthcare facilities, the replacement therapies are considered to be safer, offer better effectiveness and are applicable to a greater range of patient population, as per the study published in the Annals of Cardiothoracic Surgery, 2017.

Furthermore, the better participation by the government authorities to push more on innovation and better distribution network across the cities are expected to drive and provide steady growth to replacement procedures, over the forecast period.

North America is Expected to Hold Largest Market Share over the Forecast Period

North America is the major contributing geography for the structural heart devices market. The presence of better awareness in the society regarding the heart indications and well-organized infrastructure in the cities of the United States ad Canada, along with the faster approval process of medical devices in the region, are a few of the important factors driving the growth of the studied market in this region.

The better healthcare expenditure, boost to innovative medical device companies through funding from venture partners, and steady participation of small business innovation research in the innovative projects drives the demand of cardiovascular devices and positively impacting the growth of structural heart devices.

Competitive Landscape

The market is moderatley fragmented with signicant contribution of several public and private private companies operating at the global level. Many companies are now exploring collabroation opportunities in many of medical tourism destinations across the emerging markets of the world. Some of the top players include Abbott Laboratories, Boston Scientific Coporation, Medtronic PLC, Lepu Medical, Edwards Life Sciences Corporation, among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Cardiovascular Diseases
    • 4.2.2 Technological Advancement in Medical Devices
    • 4.2.3 Growing Participation of Government and Private Sector
  • 4.3 Market Restraints
    • 4.3.1 Less Accessibility to New Technology in the Emerging Markets
    • 4.3.2 Irregular Reimbursement Scenario
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Heart Valve Devices
    • 5.1.2 Occluders & Delivery Systems
    • 5.1.3 Annuloplasty Rings
    • 5.1.4 Other Products
  • 5.2 By Procedure
    • 5.2.1 Replacement Procedures
    • 5.2.2 Repair Procedures
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 France
      • 5.3.2.2 Germany
      • 5.3.2.3 United Kingdom
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Biomerics, LLC
    • 6.1.3 Boston Scientific Corporation
    • 6.1.4 Braile Biomedica
    • 6.1.5 Comed B.V.
    • 6.1.6 Edwards Lifesciences Corporation
    • 6.1.7 JenaValve Technology, Inc.
    • 6.1.8 Lepu Medical
    • 6.1.9 LivaNova PLC
    • 6.1.10 Medtronic PLC

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.